These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15696900)

  • 1. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease].
    Gorostidi M; Marín R;
    Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension in patients with chronic renal disease].
    Laville M
    Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different antihypertensive agents on the overall cardiovascular risk profile.
    Crepaldi G; Pessina AC; Rahn KH
    J Hypertens Suppl; 1993 Dec; 11(6):S37-9. PubMed ID: 8169382
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension: a review and rationale of treatment.
    Copley JB; Rosario R
    Dis Mon; 2005; 51(10-11):548-614. PubMed ID: 16360376
    [No Abstract]   [Full Text] [Related]  

  • 5. The wider issue of potential early-onset target organ damage.
    Jolobe OM
    Am J Emerg Med; 2010 May; 28(4):529-30. PubMed ID: 20466248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the best treatments for early chronic kidney disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.
    Saweirs WW; Goddard J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 9():ix31-38. PubMed ID: 17998230
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Should drug treatment be started with monotherapy or combination therapy for patients with hypertension].
    Kato J; Eto T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():254-7. PubMed ID: 16983767
    [No Abstract]   [Full Text] [Related]  

  • 11. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive therapy: who should be treated and to which target?].
    Waeber B; Burnier M
    Rev Med Suisse; 2006 Jan; 2(48):123-4, 126-7. PubMed ID: 16463797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When is blood pressure lowering needed?].
    Tikkanen I; Tikkanen T
    Duodecim; 1999; 115(8):945-9. PubMed ID: 11859528
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of blood pressure control in chronic kidney disease.
    Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing vascular events due to elevated blood pressure.
    Yusuf S
    Circulation; 2006 May; 113(18):2166-8. PubMed ID: 16684871
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments.
    Simpson FO
    J Hypertens; 1997 Jan; 15(1):1-2. PubMed ID: 9050964
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapy: the future has already come.
    Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):2. PubMed ID: 20459512
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.